Drug
Adrenomedullin clinical trials
Also written ADM.
Keep track of what changes. Save the Adrenomedullin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2009 (1)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2016 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 6
Danish Headache Center (2) · Harvard Medical School (HMS and HSDM) (1) · National Cerebral and Cardiovascular Center, Japan (1) · The University of Texas Health Science Center, Houston (1) · Italian Sarcoma Group (1)
Often tested with
Tested in the same studies.
Ifosfamide (1) · Cyclophosphamide (1) · Ethylene Oxide (1) · Busulfan/Melphalan Regimen (1) · Vincristine (1)
Related medicines
As reviewed, each with the page that says it.
- One of Bronchodilator Agents source
Studies
Open first, then newest update. How each study uses Adrenomedullin is read from its arms, and is right about nine times in ten.
Testing it · 6
- Selective Activation of the Adrenomedullin Receptors in MigraineRecruitingNot applicableDanish Headache CenterNCT07451769Written as Adrenomedullin
- Hypersensitivity to Adrenomedullin in Post-Traumatic HeadacheRecruitingNot applicableDanish Headache CenterNCT07059546Written as Adrenomedullin
- OptimizeD Pilot StudyCompletedPhase 3Harvard Medical School (HMS and HSDM)NCT06153004Written as Antidepressant medication (ADM)
- Adrenomedullin for CADASILCompletedPhase 2National Cerebral and Cardiovascular Center, JapanNCT06072118Written as Adrenomedullin
- Esthetic Outcomes Following Immediate Implant Combine With Soft Tissue AugmentationCompletedPhase 4The University of Texas Health Science Center, HoustonNCT02864862Written as ADM
- Protocol for the Treatment of Metastatic Ewing SarcomaCompletedPhase 2Italian Sarcoma GroupNCT02727387Written as ADM